Ian McGovern

Seqirus (United States) — United States

Medicine · Health Sciences

14h-index598citations67works6.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(40), Respiratory viral infections research(35), Vaccine Coverage and Hesitancy(9), Mechanical Circulatory Support Devices(7), Transplantation: Methods and Outcomes(7)

Publications67 total

P-1472. Comparable Vaccine Effectiveness of Adjuvanted and High-Dose Influenza Vaccines in Preventing Test-Confirmed Influenza Outcomes, including Hospitalization, in Overall and High-Risk Older Adults: A Test-Negative Design Study During 2022-2023 and 2023-2024
Open Forum Infectious Diseases·2026Open Access
P-1473. Estimated Relative Effectiveness and Public Health Impact of Cell-Based Versus Egg-Based Influenza Vaccines During the 2023–2024 Season in the United States
Open Forum Infectious Diseases·2026Open Access
Estimated Relative Effectiveness and Public Health Impact of Cell‐Based Versus Egg‐Based Influenza Vaccines During the 2022–2023 Season in the United States
Influenza and Other Respiratory Viruses·2025· 1 citedOpen Access
Superior Effectiveness and Estimated Public Health Impact of Cell- Versus Egg-Based Influenza Vaccines in Children and Adults During the US 2023–2024 Season
Infectious Diseases and Therapy·2025Open Access
The impact of egg adaptation and immune imprinting on influenza vaccine effectiveness
Vaccine·2025· 4 citedOpen Access
Comparable effectiveness of MF59®-adjuvanted and high-dose quadrivalent inactivated influenza vaccines for prevention of test-confirmed influenza during the 2022-2023 influenza season
International Journal of Infectious Diseases·2025Open Access
Relative Impfeffektivität des adjuvantierten, quadrivalenten Influenza-Impfstoffs (aQIV) vs. des hochdosierten, quadrivalenten Influenza-Impfstoffs (HD-QIV) hinsichtlich der Prävention testbestätigter Influenza (Saison 2022/23)
Pneumologie·2025
Improving quality and outcomes of extracorporeal cardiopulmonary resuscitation in refractory cardiac arrest: the Phoenix ECPR project
BMJ Open Quality·2025· 12 citedOpen Access
P-626. Relative Vaccine Effectiveness of Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines Against Test-Confirmed Influenza in the United States 2022-23 Influenza Season
Open Forum Infectious Diseases·2025· 1 citedOpen Access
164. Effectiveness of Adjuvanted Inactivated Influenza Vaccine versus High-Dose Inactivated Influenza Vaccine Against PCR-Confirmed Influenza among Adults ≥65 years: A Pragmatic Randomized Study
Open Forum Infectious Diseases·2025· 1 citedOpen Access
P-2364. Estimated Additional Burden Averted for the 2022-2023 influenza season from Use of Cell-Based Influenza Vaccines Compared to Egg-Based Influenza Vaccines Among People 0-64 Years of Age in the United States
Open Forum Infectious Diseases·2025Open Access
P-707. Relative Effectiveness of Cell-Based Influenza Vaccines versus Egg-Based Influenza Vaccines: A Review of Test-Confirmed and Clinical Diagnosis-Based Outcomes
Open Forum Infectious Diseases·2025Open Access
Implementing and evaluating shared decision-making before transcatheter aortic valve implantation with a dedicated pathway and questionnaire
European Heart Journal Open·2024Open Access
Relative effectiveness of adjuvanted versus non-adjuvanted influenza vaccines in older adults with risk factors for influenza complications during the 2019–2020 U.S. influenza season
Vaccine·2024· 1 citedOpen Access
Relative Effectiveness of the MF59-Adjuvanted Influenza Vaccine Versus High-Dose Influenza Vaccine in Older Adults With Influenza Risk Factors During the 2019–2020 US Influenza Season
Open Forum Infectious Diseases·2024· 6 citedOpen Access
Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017–2020 influenza seasons
International Journal of Infectious Diseases·2024· 5 citedOpen Access
Relative Vaccine Effectiveness of Cell- vs Egg-Based Quadrivalent Influenza Vaccine Against Test-Confirmed Influenza Over 3 Seasons Between 2017 and 2020 in the United States
Open Forum Infectious Diseases·2024· 17 citedOpen Access
Global analysis of respiratory viral circulation and timing of epidemics in the pre–COVID-19 and COVID-19 pandemic eras, based on data from the Global Influenza Surveillance and Response System (GISRS)
International Journal of Infectious Diseases·2024· 59 citedOpen Access
Number of Influenza Risk Factors Informs an Adult's Increased Potential of Severe Influenza Outcomes: A Multiseason Cohort Study From 2015 to 2020
Open Forum Infectious Diseases·2024· 10 citedOpen Access
Incidence of Influenza-related Medical Encounters and the Associated Healthcare Resource Use and Complications Across Adult Age Groups in the United States During the 2015–2020 Influenza Seasons
Clinical Infectious Diseases·2024· 4 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Mendel Haag(25), Alina Bogdanov(7), Brenda L. Coleman(5), Jerry Mitchell(5), Alex Dean(5), Binu Raj(4), Katherine Cappell(4), Davorin Sef(4), Alessandra Verzelloni Sef(4), Vladimir Trkulja(4), Christopher Walker(4), Alicia Stein(4), Ruth Sanderson(3), Steven Rockman(3), Sankarasubramanian Rajaram(3), John Youhanna(3), Fabio De Robertis(3), Ulrich Stock(3), Sheena G. Sullivan(3), Sumesh Thiruthalil(3)